A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device

Inclusion Criteria: * A. Patient has signed an IRB approved, study specific Informed Patient Consent Form. * B. Patient is a male or non-pregnant female age 45 years or younger at time of study device implantation. * C. Patient is a candidate for repair of one longitudinal vertical tear (bucket handle) fully located in the red-white (vascular-avascular) zone of the meniscus (3-5 mm from the synovial-meniscus junction) or repair of one longitudinal vertical tear (bucket handle) primarily located in the red-white zone of the meniscus, but partially (\< 30% of total length) extending into the red zone (\< 3 mm from the synovial-meniscus junction) and/or into the white zone (\> 5 mm from the synovial-meniscus junction). * D. Patient does not require more than three BioDuct® Meniscal Repair Devices for the meniscal tear. * E. Patient requires suture only for fixation at the site where the study device will be used. * F. Patient is willing and able to comply with postoperative scheduled MRI and clinical evaluations and rehabilitation. Exclusion Criteria: * G. Patient has a Body Mass Index (BMI) \> 35. * H. Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation. * I. Patient has horizontal, transverse, degenerative complex tears. * J. Patient has ACL and/or PCL deficiencies within the operative knee and is not undergoing concomitant repair of these deficiencies. * K. Patient requires bilateral meniscal repair. * L. Patient requires meniscectomy. * M. Patient presents with abnormal degenerative osteoarthritis of the joint \[e.g. International Cartilage Repair Society (ICRS) Grade III or higher and/or Modified Outerbridge Grade III or higher\]. * N. Patient has undergone previous meniscal repair to the operative knee. * O. Patient has a knee joint with greater than 5º anatomic axis misalignment. * P. Patient has active synovitis. * Q. Patient is a prisoner.